Literature DB >> 15286735

Recombinant biologics for treatment of bleeding disorders.

Paul Bishop1, Jeff Lawson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286735     DOI: 10.1038/nrd1443

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  6 in total

Review 1.  Transgenic bovine as bioreactors: Challenges and perspectives.

Authors:  Paulo S Monzani; Paulo R Adona; Otávio M Ohashi; Flávio V Meirelles; Matthew B Wheeler
Journal:  Bioengineered       Date:  2016-05-11       Impact factor: 3.269

Review 2.  Bio-inspired nanomedicine strategies for artificial blood components.

Authors:  Anirban Sen Gupta
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-15

Review 3.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

4.  Fluorescence Correlation Spectroscopy Reveals Efficient Cytosolic Delivery of Protein Cargo by Cell-Permeant Miniature Proteins.

Authors:  Rebecca F Wissner; Angela Steinauer; Susan L Knox; Alexander D Thompson; Alanna Schepartz
Journal:  ACS Cent Sci       Date:  2018-09-27       Impact factor: 14.553

5.  Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding.

Authors:  Steven D Hughes; Paul D Bishop; Richard Garcia; Tracy Zhang; W Allan Alexander
Journal:  Ann Surg Innov Res       Date:  2009-11-19

6.  Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice.

Authors:  Sriram Krishnamoorthy; Tongyao Liu; Douglas Drager; Susannah Patarroyo-White; Ekta Seth Chhabra; Robert Peters; Neil Josephson; David Lillicrap; Richard S Blumberg; Glenn F Pierce; Haiyan Jiang
Journal:  Cell Immunol       Date:  2015-12-29       Impact factor: 4.868

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.